Noteworthy, various studies have shown that antagonists have favourable pharmacokinetic profiles and better tumour visualization compared to agonists, thanks to their ability to bind multiple conformational states of SSTR2, despite poor internalization rates19,20. Here, SSTR2 is linked to neoplasm.